Doheny Asset Management /Ca Abb Vie Inc. Transaction History

Doheny Asset Management /Ca

$122 Million
Q1 2024

A detailed history of Doheny Asset Management /Ca transactions in Abb Vie Inc. stock. As of the latest transaction made, Doheny Asset Management /Ca holds 17,721 shares of ABBV stock, worth $3.28 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares

17,721

Previous 16,185 9.49%

Holding current value

$3.28 Million

Previous $2.51 Million 28.67%

% of portfolio

2.65%

Previous 2.46%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $245,483 - $279,705	1,536 Added 9.49%	17,721 $3.23 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $206,400 - $232,455	-1,500 Reduced 8.48%	16,185 $2.51 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $347,334 - $402,090	-2,600 Reduced 12.82%	17,685 $2.64 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $19,876 - $24,735	-150 Reduced 0.73%	20,285 $2.73 Million
Q1 2023 May 16, 2023	BUY	$144.61 - $166.54 $503,532 - $579,892	3,482 Added 20.54%	20,435 $3.26 Million

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $578,274 - $693,502	-4,181 Reduced 19.78%	16,953 $2.74 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $113,273 - $129,916	-844 Reduced 3.84%	21,134 $2.84 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $13,197 - $16,375	-100 Reduced 0.45%	21,978 $3.56 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $254,609 - $322,154	-2,370 Reduced 9.69%	22,078 $2.99 Million
Q3 2021 Oct 22, 2021	SELL	$106.4 - $120.78 $208,544 - $236,728	-1,960 Reduced 7.42%	24,448 $2.64 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $54,183 - $60,363	-515 Reduced 1.91%	26,408 $2.98 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $198,462 - $218,482	1,940 Added 7.77%	26,923 $2.91 Million
Q4 2020 Feb 26, 2021	BUY	$80.49 - $108.67 $2.01 Million - $2.71 Million	24,983 New	24,983 $2.68 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $1.65 Million - $1.93 Million	-19,173 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $1.65 Million - $1.93 Million	19,173 New	19,173 $1.68 Million

Others Institutions Holding ABBV

# of Institutions

3,647

Shares Held

1.23B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $327B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.

Account

Doheny Asset Management /Ca Abb Vie Inc. Transaction History